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ORIGINAL RESEARCH
Abstract: Toll-like receptor 4 (TLR4) is the transuding subunit of lipopolysaccharide receptor
and an important intracellular signal pathway of the innate immune response. Published data
about the relationship between TLR4 mutations and atopy/asthma are not consistent. This
study was performed to detect two commonly reported Asp299Gly and Thr399Ile
polymorphisms in TLR4 gene in Singaporean Chinese and their possible association with
atopy-related phenotypes. A total of 117 unrelated Singapore residents were randomly selected
for this study. Among them, atopy was evident in 66 subjects while 61 had allergic rhinitis.
Twenty-one patients had concomitant asthma and 17 were atopic. In all subjects, neither the
Asp299Gly nor Thr399Ile polymorphism was found by DNA sequencing. This discrepant
result could be due to the ethnic variation of allelic distribution in TLR4 gene. Although it is
still debatable whether there is any role of TLR4 polymorphisms on atopy-related phenotypes,
one needs to develop an appropriate model to investigate the interactions between genetic
variations and environmental factors that contribute to the complex traits in allergic diseases.
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Introduction
Toll-like receptor 4 (TLR4) is one of the principal receptors for bacterial endotoxin
recognition and an important intracellular signal pathway of the innate immune
response (Aderem et al 2000; Lien et al 2000). Recently, there is evidence that
endotoxin exposure during early life is protective against the development of atopy
and asthma (Strachn 2000; Liu 2002). TLR4 is therefore reasonably suspected as a
candidate gene for studying interaction between genetic variation and environmental
factors for the development of atopic diseases.
Human TLR4 gene is located at chromosome 9q32-33 and comprises three exons
spanning about 10 kb (http://www.ncbi.nlm.nih.gov; AF177765). Twelve rare amino
acid variants of TLR4 were reported in 2001 (Smirnova et al 2001). Raby and
colleagues have identified an additional 29 polymorphisms of this gene (Raby et al
2002). However, most association studies have concentrated on two positions: an A
to G polymorphism at nucleotide 896 from the start codon of the human TLR4 gene
resulting in an aspartic acid to glycine substitution at position 299 of the amino acid
sequence (Asp299Gly); and a C to T polymorphism at nucleotide position 1196
resulting in a threonine to isoleucine substitution at position 399 of the amino acid
sequence (Thr399Ile). Many studies have reported an association between
polymorphisms at TLR4 Asp299Gly and Thr399Ile with clinical diseases (Lorenz et
al 2002; Michel et al 2003; Werner et al 2003; Yang et al 2004). In 2000, Arbour and
colleagues first reported that TLR4 mutation were associated with endotoxin
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hyporesponsiveness in humans (Arbour et al 2000). Using
an in vitro cultured cell approach, the same group reported
that Asp299Gly mutation interrupted TLR4-mediated
lipopolysaccaride (LPS) signaling (Schwartz 2001b). The
study provides genetic evidence that human TLR4
Asp299Gly mutation could be associated with differences
in LPS responsiveness and, consequently, could alter the
ability of the host to respond to environmental stimulus
(Schwartz 2001b).
Recently, polymorphisms of TLR4 were reported to be
associated with the severity of atopy (Yang et al 2004) and
with a modified response to endotoxin in asthmatics (Werner
et al 2003). However, some studies were unable to confirm
these two common polymorphisms on human TLR4 gene
or its associated atopy-related phenotypes (Raby et al 2002;
Noguchi et al 2004). This study is therefore designed to
screen the existence of these two common TLR4 poly-
morphisms (Asp299 Gly and Thr399Ile) and the association
with atopy-related phenotypes in a Singaporean Chinese
population.
Materials and methods
A total of 117 unrelated Singapore Chinese residents, aged
from 9 to 72 years with a mean age of 31.7 ± 11.7 years,
were investigated. Among them, atopy was evident in 66
subjects, and 51 were non-atopic. In atopic subjects, 61
experienced allergic rhinitis. Twenty-one patients had
concomitant asthma and 17 of them were atopic. They were
randomly called during a national rhinitis survey study to
attend a rhinologic examination in the ENT outpatient clinic
of the National University Hospital of Singapore. All
subjects were carefully interviewed by an attending
physician for their medical and family history, and a
thorough inspection of the nose was performed. Peripheral
blood samples were taken for allergy screening tests and
for DNA extraction. All study subjects gave their informed
consent prior to the study. This study was approved by the
Institutional Review Board of the National University of
Singapore and funded by the Academic Research Fund from
the same university.
Diagnosis of atopy and its related diseases were made
according to the following criteria (Bousquet et al 2001):
1. Atopy: a positive serum specific IgE (equal or more than
0.35 U/mL) to at least one of the inhalant allergens (house
dust mites) tested.
2. Rhinitis: the occurrence of two or more symptoms (nasal
obstruction, rhinorrhea, sneezing, and itchy nose) on
most days during the past year. If patients also had atopy,
a diagnosis of allergic rhinitis was given.
3. Asthma: a history of paroxysmal attacks of breathless-
ness commonly associated with a tightness of the chest
and wheezing as previously confirmed by a physician.
Genomic DNA was extracted using a modified phenol-
chloroform procedure. The polymorphism of TLR4 was
identified by sequence analysis in 117 subjects. PCR was
carried out in a volume of 25 µL containing 30 ng genomic
DNA, 10 × buffer, 0.2 mmol/L dNTPs, and 1 unit Taq
polymerase (Qiagen, Hilden, Germany). The primers were:
5´- TCT AGA GGG CCT GTG CAA TT -3´ (forward) and
5´- TGA AAA CTC ACT CAT TTG TTT CAA -3´ (reverse)
at a concentration of 0.4 µmol/L (Lorenz et al 2002). PCR
were optimized using denaturing for 2 min at 94 ºC. The
PCR cycle was set at 94 ºC for 30 s, 54 ºC for 30 s, and 72 ºC
for 40 s totally for 35 cycles, followed by 72 ºC for 5 min.
The sizes of the generated PCR products were 496 bp. Before
sequencing, the PCR products were purified with QIAquick
PCR purification kit (Qiagen, Hilden, Germany).
Sequencing reactions were performed using the BIG Dye
Terminator Cycle Sequencing Ready Reaction Kit (PE
Applied Biosystems, Foster City, CA, USA). The sequenced
products were purified by ethanol precipitation, following
which the DNA pellet was dissolved in 4 µL of loading dye
(Deionized formamide, PE Applied Biosystems, Foster City,
CA, USA) and analyzed on an Applied Biosystems Genetic
Analyser 3100 (PE Applied Biosystems, Foster City, CA,
USA) in the Department of Pediatrics, National University
of Singapore.
Results and discussion
In all 117 subjects, we were unable to identify poly-
morphisms either at TLR4 Asp299Gly or Thr399Ile. It
appeared that the allele frequencies of mutation at these two
positions are rare (lower than 1%) in the Singaporean
Chinese population. This study indicated that all sequenced
samples had Asp at amino acid 299 and Thr at amino acid
399 (Figure 1). In addition, we were unable to detect any
polymorphism within the DNA fragments that were
amplified and sequenced in this study.
Allele frequencies of TLR4 Asp299Gly and Thr399Ile
are found to be low in published studies. Asp299Gly is
present at frequencies between 3.3% and 9.4%, while those
of Thr399Ile are between 3.7% and 11% in several
Caucasian studies (Table 1). A study performed in 32
asthmatic Japanese showed that Gly299 variant wasTherapeutics and Clinical Risk Management 2005:1(3) 245
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undetectable in all patients (Noguchi et al 2004). In another
Japanese study, the Asp299Gly allele of the TLR4 gene was
undetectable in any of the specimens from 107 healthy
volunteers and 168 patients with various diseases (Okayama
et al 2002). From the available data, it seems that the
polymorphisms of TLR4 at amino acid position of 299 and
399 are rare in Asian population.
Exposure to bacterial endotoxin has received
considerable attention as a potential risk factor for the
development of asthma and atopic diseases (Schwartz
2001a). As a receptor for LPS, TLR4 is one of the most
commonly investigated candidate genes for studying
interaction between genetic variation and environmental
factors for the development of atopic or atopy-related
diseases. Although associations between polymorphisms of
Asp299Gly and Thr399Ile at TLR4 gene and atopic diseases
have been reported by some studies, they may not be the
key players in the development of atopic phenotypes.
Otherwise, one could expect to confirm these poly-
morphisms in a different population since allergic disease
is a common disease worldwide.
TLR4 is a candidate gene for atopic diseases because of
its important biologic characteristics. It is possible that
polymorphisms at other positions of TLR4 might play an
Table 1 Summary of association studies regarding the polymorphisms at Asp299Gly and Thr399Ile
Asp299Gly Thr399Ile
Country/ethnic Nr of G allele T allele Association with diseases
Author(s) group study subjects frequency (%) frequency (%) Yes/No Diseases for comparison
Agnese 2002 US Patients: 77 NA NA Yes Gram-negative infections
Controls: 39
Lorenz 2002 France Patients: 91 6–8 6.6–11 Yes Gram-negative septic shock
Controls: 73
Werner 2003 Germany 334 8.3 8.6 Yes Modify endotoxin effects on
asthma
Michel 2003 Australia 118 6.6–9.4 6.6–9.4 Yes Systemic inflammatory
hyporesponsiveness 100%
linkage disequilibrium
Reindl 2003 Australia 190 6.05 5.8 Yes Multiple sclerosis 
Yang 2004 US (Caucasians) Family: 336 5.9–8.1 NA Yes and No Atopy severity, but not asthma
Raby 2002 Canada (various  90 NA NA No Asthma or atopy-related
populations) phenotypes
Noguchi 2004 Japan 32 Not detected NA No Asthma
Folwaczny 2004 Germany Patients: 122 4.13.3 4.53.7 No Chronic periodontitis
Control: 122
Smirnova 2001 US (Caucasians) 348 7 7 NA NA 
Okayama 2002 Japan Patients: 168 Not detected NA NA NA 
Controls: 107
Abbreviations: NA, not available.
Figure 1 Sequence analysis of TLR4 at amino acid position of 299 and 399.
(a) AA homozygote at amino acid position 299; (b) CC homozygote at amino
acid position 399. All sequences are 5´-3´.
(a)
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important role in atopy-related phenotypes and that is in
combination with the environmental exposure of bacterial
endotoxin. Alternatively, it is also possible that genetic
susceptibility to asthma and atopic-related phenotypes might
be different in various populations. This notion was
supported by the recent genome-wide studies for identifying
the asthma susceptibility loci in ethnically diverse
populations (Xu et al 2001; Hakonarson et al 2002). In view
of the conflicting evidence, future studies are needed to
identify the key genes for atopic phenotypes and to
investigate the interactions between genetic and environ-
mental factors influencing the complex trait of allergic
diseases.
In summary, we were unable to detect the poly-
morphisms at Asp299Gly or Thr399Ile of TLR4 in
Singaporean Chinese. Our results suggest that these two
polymorphisms in TLR4 could not be the key player in
Singaporean Chinese with atopy or atopic-related
phenotypes.
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